Wasmuth Anja, van de Loo Iris, Domberg Julia, Harbeck Birgit
III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Practice for Internal medicine, Diabetology und Endocrinology Bremen, Bremen, Germany.
Endocrine. 2025 Jun;88(3):852-862. doi: 10.1007/s12020-025-04192-0. Epub 2025 Feb 25.
Patients with adrenal insufficiency (AI) are known to have a higher cardiovascular risk (CVR) than the normal population. In particular arteriosclerosis, coronary heart disease, arterial hypertension, hyperlipoproteinemia as well as metabolic disturbances contribute to the increased morbidity and mortality. Aim of this study was to evaluate known CVR factors along with the quality of care by the treating physicians.
To this end the medical records of AI patients were screened for CVR factors and the treatment initiated was documented. In addition, a questionnaire evaluating CVR factors was analyzed if available.
In total, 327 AI patients were included in the study. At least 298 of these patients were found to have one or more CVR factors. Ninety-one patients were diagnosed with arterial hypertension, of these 40 patients (44%) still showed increased blood pressure (BP) values. Of all AI patients, about 25% (n = 83) did not have measurements to calculate their BMI, even though obesity is known as a major risk factor for cardiovascular events. Out of 46 patients with diabetes, one-quarter still had increased HbA1c values. Regarding hyperlipoproteinemia, only 2% of AI patients achieved normal lipid values across all parameters (n = 8). Interestingly, at least one lipid variable was untested in 150 patients (46%).
Our study demonstrates (1) the high rate of CVR factors in AI patients, leading to increased morbidity and eventually mortality, (2) AI patients are inadequately monitored and treated for CVR factors, (3) treating physicians should be aware of this risk to minimize complications where possible.
已知肾上腺功能不全(AI)患者的心血管风险(CVR)高于正常人群。特别是动脉硬化、冠心病、动脉高血压、高脂蛋白血症以及代谢紊乱导致发病率和死亡率增加。本研究的目的是评估已知的CVR因素以及治疗医生的护理质量。
为此,筛查了AI患者的病历以寻找CVR因素,并记录开始的治疗。此外,如有可用的评估CVR因素的问卷也进行了分析。
本研究共纳入327例AI患者。其中至少298例患者被发现有一个或多个CVR因素。91例患者被诊断为动脉高血压,其中40例患者(44%)血压值仍升高。在所有AI患者中,约25%(n = 83)没有测量数据来计算其体重指数(BMI),尽管肥胖是心血管事件的主要危险因素。在46例糖尿病患者中,四分之一的患者糖化血红蛋白(HbA1c)值仍升高。关于高脂蛋白血症,只有2%的AI患者所有参数的血脂值均正常(n = 8)。有趣的是,150例患者(46%)至少有一项血脂变量未检测。
我们的研究表明:(1)AI患者中CVR因素的发生率很高,导致发病率增加并最终导致死亡率增加;(2)对AI患者的CVR因素监测和治疗不足;(3)治疗医生应意识到这种风险,尽可能减少并发症。